Financhill
Back

Insulet Quote, Financials, Valuation and Earnings

Insulet Price Quote

$266.39
-0.16 (3.83%)
(Updated: December 21, 2024 at 5:42 AM ET)

Insulet Key Stats

Buy
64
Insulet (PODD) is a Buy

Day range:
$256.56 - $270.70
52-week range:
$160.19 - $279.77
Dividend yield:
0%
P/E ratio:
90.66
P/S ratio:
10.27
P/B ratio:
16.72%

Volume:
1.3M
Avg. volume:
653.1K
1-year change:
28.17%
Market cap:
$18.7B
Revenue:
$1.7B
EPS:
$5.84

How Much Does Insulet Make?

Data Unavailable

Is Insulet Growing As A Company?

Data Unavailable

Insulet Stock Price Performance

  • Did Insulet Stock Go Up Last Month?
    Insulet share price went down by -0.01% last month
  • Did PODD's Share Price Rise Over The Last Year?
    PODD share price rose by 28.17% over the past 1 year

What Is Insulet 52-Week High & Low?

  • What Is Insulet’s 52-Week High Share Price?
    Insulet has traded as high as $279.77 over the past 52 weeks
  • What Is Insulet’s 52-Week Low Share Price?
    Insulet has traded as low as $160.19 over the past 52 weeks

Insulet Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Insulet?

Data Unavailable

Is Insulet Cash Flow Positive?

Data Unavailable

Insulet Return On Invested Capital

Data Unavailable

Insulet Earnings Date & Stock Price

  • What Is Insulet's Stock Price Today?
    A single share of PODD can be purchased today for 266.55
  • What Is Insulet’s Stock Symbol?
    Insulet trades on the nasdaq under the ticker symbol: PODD
  • When Is Insulet’s Next Earnings Date?
    The next quarterly earnings date for Insulet is scheduled on February 21, 2025
  • When Is PODD's next ex-dividend date?
    Insulet's next ex-dividend date is December 22, 2024
  • How To Buy Insulet Stock?
    You can buy Insulet shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Insulet Competitors

  • Who Are Insulet's Competitors?
    Below is a list of companies who compete with Insulet or are related in some way:
    • Boston Scientific Corp (BSX)
    • Globus Medical Inc (GMED)
    • Haemonetics Corp (HAE)
    • LeMaitre Vascular Inc (LMAT)
    • Tandem Diabetes Care Inc (TNDM)

Insulet Dividend Yield

Data Unavailable

Insulet Analyst Estimates

YoY Growth Past Surprise
EPS: 45.95% 18.29%
Revenue: 25.7% 4.74%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 285.63
Upside from Last Price: 7.16%

Major Shareholders

Data Unavailable